19-13906446-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017721.5(CC2D1A):c.5A>T(p.His2Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000402 in 1,518,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017721.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CC2D1A | NM_017721.5 | c.5A>T | p.His2Leu | missense_variant | 1/29 | ENST00000318003.11 | NP_060191.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CC2D1A | ENST00000318003.11 | c.5A>T | p.His2Leu | missense_variant | 1/29 | 1 | NM_017721.5 | ENSP00000313601.6 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000525 AC: 6AN: 114240Hom.: 0 AF XY: 0.0000631 AC XY: 4AN XY: 63348
GnomAD4 exome AF: 0.0000256 AC: 35AN: 1366438Hom.: 0 Cov.: 30 AF XY: 0.0000237 AC XY: 16AN XY: 673926
GnomAD4 genome AF: 0.000171 AC: 26AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74452
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.5A>T (p.H2L) alteration is located in exon 1 (coding exon 1) of the CC2D1A gene. This alteration results from a A to T substitution at nucleotide position 5, causing the histidine (H) at amino acid position 2 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 14, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at